Daniel E. Geffken

Insider Reports History

Entity
Individual
Location
Damonmill Square, Suite 6 A, Concord, Massachusetts
Signature
/s/ John Dunn, Esq., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel E. Geffken:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PHOENIX BIOTECH ACQUISITION CORP. Chief Financial Officer Class A Common Stock 10K $100K $10.00 Feb 14, 2024 Direct
Eloxx Pharmaceuticals, Inc. INTERIM CFO Common Stock 50K $36K $0.72 Nov 29, 2021 Direct
WINDTREE THERAPEUTICS INC /DE/ Director Common Stock 2.18K $2.22K $1.02 Aug 23, 2023 Direct
CalciMedica, Inc. Interim CFO Warrant 10K May 17, 2024 By SG Dan Equity Holdings, LLC
WINDTREE THERAPEUTICS INC /DE/ Director Stock Option (Right to Buy) 3.05K Aug 23, 2023 Direct
ProMIS Neurosciences Inc. Chief Financial Officer Option (right to buy) 2.5K Oct 26, 2023 Direct

Insider Reports Filed by Daniel E. Geffken

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CALC CalciMedica, Inc. May 17, 2024 1 $0 4 May 20, 2024 Interim CFO
CERO PHOENIX BIOTECH ACQUISITION CORP. Feb 14, 2024 1 $0 4 Feb 16, 2024 Chief Financial Officer
PMN ProMIS Neurosciences Inc. Oct 26, 2023 1 $0 4 Oct 30, 2023 Chief Financial Officer
WINT WINDTREE THERAPEUTICS INC /DE/ Aug 23, 2023 2 $0 4 Aug 29, 2023 Director
CALC CalciMedica, Inc. Mar 20, 2023 2 $0 4 May 3, 2023 Interim CFO
CALC CalciMedica, Inc. Mar 20, 2023 0 $0 3 May 3, 2023 Interim CFO
PMN ProMIS Neurosciences Inc. Jul 7, 2022 0 $0 3 Jul 7, 2022 Chief Financial Officer
WINT WINDTREE THERAPEUTICS INC /DE/ Jun 7, 2022 2 $0 4 Jun 9, 2022 Director
ELOX Eloxx Pharmaceuticals, Inc. Nov 29, 2021 1 $36K 4 Dec 1, 2021 INTERIM CFO
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 8, 2021 1 $0 4 Oct 12, 2021 Chief Financial Officer
PBAX PHOENIX BIOTECH ACQUISITION CORP. Oct 5, 2021 0 $0 3 Oct 5, 2021 Chief Financial Officer
WINT WINDTREE THERAPEUTICS INC /DE/ Jun 15, 2021 1 $0 4 Jun 17, 2021 Director